BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8260650)

  • 1. Protein and lipid kinase activation cascades in interleukin-2 receptor signalling.
    Williamson P; Merida I; Gaulton G
    Semin Immunol; 1993 Oct; 5(5):337-44. PubMed ID: 8260650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of PtdIns-3-kinase and the guanine nucleotide binding proteins p21ras during signal transduction by the T cell antigen receptor and the interleukin-2 receptor.
    Cantrell DA; Izquierdo M; Reif K; Woodrow M
    Semin Immunol; 1993 Oct; 5(5):319-26. PubMed ID: 8260648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interleukin-2 receptor complex and signal transduction: role of the beta-chain.
    Kono T; Minami Y; Taniguchi T
    Semin Immunol; 1993 Oct; 5(5):299-307. PubMed ID: 8260646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine-rich region of the IL-2 receptor beta-chain is required for activation of phosphatidylinositol 3-kinase.
    Kanazawa T; Keeler ML; Varticovski L
    Cell Immunol; 1994 Jul; 156(2):378-88. PubMed ID: 8025955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tyrosine kinase physically associates with the beta-subunit of the human IL-2 receptor.
    Fung MR; Scearce RM; Hoffman JA; Peffer NJ; Hammes SR; Hosking JB; Schmandt R; Kuziel WA; Haynes BF; Mills GB
    J Immunol; 1991 Aug; 147(4):1253-60. PubMed ID: 1869821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The membrane proximal segment of the IL-2 receptor beta-chain acidic region is essential for IL2-dependent protein tyrosine kinase activation.
    Williamson P; Merida I; Greene WC; Gaulton G
    Leukemia; 1994 Apr; 8 Suppl 1():S186-9. PubMed ID: 8152289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IL-2 receptor complex: its structure, function, and target genes.
    Minami Y; Kono T; Miyazaki T; Taniguchi T
    Annu Rev Immunol; 1993; 11():245-68. PubMed ID: 8476561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human interleukin-2 receptor: insights into subunit structure and growth signal transduction.
    Fung MR; Greene WC
    Semin Immunol; 1990 Mar; 2(2):119-28. PubMed ID: 2129904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signalling by cytokines interacting with the interleukin-2 receptor gamma chain.
    Demoulin JB; Renauld JC
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):243-56. PubMed ID: 10068058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 binding activates a tyrosine-phosphorylated phosphatidylinositol-3-kinase.
    Merida I; Diez E; Gaulton GN
    J Immunol; 1991 Oct; 147(7):2202-7. PubMed ID: 1655887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling.
    Nakamura Y; Russell SM; Mess SA; Friedmann M; Erdos M; Francois C; Jacques Y; Adelstein S; Leonard WJ
    Nature; 1994 May; 369(6478):330-3. PubMed ID: 8183373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupling of the IL2 receptor complex with non-receptor protein tyrosine kinases.
    Miyazaki T; Taniguchi T
    Cancer Surv; 1996; 27():25-40. PubMed ID: 8909793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of the human interleukin 4 receptor (IL-4R)-derived acidic motif revealed by cytoplasmic domain chimeras of the IL-4R alpha chain and the IL-2R beta chain.
    Deutsch HH; Chung J; Kalthoff FS
    Cytokine; 1998 May; 10(5):331-6. PubMed ID: 9619370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protooncogene-encoded protein kinases in interleukin-2 signal transduction.
    Reed JC; Torigoe T; Turner BC; Merida I; Gaulton G; Saragovi HU; Rapp UR; Taichman R
    Semin Immunol; 1993 Oct; 5(5):327-36. PubMed ID: 8260649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diacylglycerol kinase inhibition prevents IL-2-induced G1 to S transition through a phosphatidylinositol-3 kinase-independent mechanism.
    Flores I; Jones DR; Ciprés A; Díaz-Flores E; Sanjuan MA; Mérida I
    J Immunol; 1999 Jul; 163(2):708-14. PubMed ID: 10395661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected effects of the IL-2 receptor alpha subunit on high affinity IL-2 receptor assembly and function detected with a mutant IL-2 analog.
    Kuziel WA; Ju G; Grdina TA; Greene WC
    J Immunol; 1993 Apr; 150(8 Pt 1):3357-65. PubMed ID: 8468475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM
    EXS; 1993; 65():131-65. PubMed ID: 8380735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of sphingosine kinase mediates suppressive effect of interleukin-6 on human multiple myeloma cell apoptosis.
    Li QF; Wu CT; Duan HF; Sun HY; Wang H; Lu ZZ; Zhang QW; Liu HJ; Wang LS
    Br J Haematol; 2007 Sep; 138(5):632-9. PubMed ID: 17686057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases.
    Kubota Y; Angelotti T; Niederfellner G; Herbst R; Ullrich A
    Cell Growth Differ; 1998 Mar; 9(3):247-56. PubMed ID: 9543391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.